Results 231 to 240 of about 1,231,536 (373)
Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence
Molecular Oncology, EarlyView.The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular Zuzana Liblova, Dominika Maurencova, Barbora Salovska, Marek Kratky, Tomas Mracek, Zuzana Korandova, Alena Pecinova, Pavla Vasicova, David Rysanek, Ladislav Andera, Ivo Fabrik, Rudolf Kupcik, Pavel Kashmel, Pinky Sultana, Vojtech Tambor, Jiri Bartek, Josef Novak, Marie Vajrychova, Zdenek Hodny +18 morewiley +1 more sourcePosition paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations. [PDF]
EClinicalMedicine, 2023 Leone AG, Casolino R, Trapani D, Miceli R, Massagrande M, Morano F, La Verde N, Dalu D, Berardi R, Marsoni S, Lambertini M, Iula B, Carieri E, Converti M, Di Maio M, Beretta GD, Perrone F, Pietrantonio F, Cinieri S, Italian Foundation of Medical Oncology (Fondazione AIOM), Italian Association of Medical Oncology (AIOM). +20 moreeuropepmc +1 more sourceEarly metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles
Molecular Oncology, EarlyView.Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea +9 morewiley +1 more sourceNEURO/MEDICAL ONCOLOGY [PDF]
Neuro-Oncology, 2013 P. Ambady, M. Holdhoff, C. Ferrigno, S. Grossman, M. D. Anderson, D. Liu, C. Conrad, M. Penas-Prado, M. R. Gilbert, A. W. K. Yung, J. de Groot, T. Aoki, R. Nishikawa, K. Sugiyama, N. Nonoguchi, N. Kawabata, K. Mishima, J.-i. Adachi, K. Kurisu, F. Yamasaki, T. Tominaga, T. Kumabe, K. Ueki, F. Higuchi, T. Yamamoto, E. Ishikawa, H. Takeshima, S. Yamashita, K. Arita, H. Hirano, S. Yamada, M. Matsutani, V. Apok, S. Mills, C. Soh, K. Karabatsou, A. Arimappamagan, S. Arya, M. Majaid, S. Somanna, V. Santosh, L. Schaff, F. Armentano, C. Harrison, A. Lassman, G. McKhann, F. Iwamoto, T. Armstrong, Y. Yuan, D. Liu, A. Acquaye, E. Vera-Bolanos, K. Diefes, L. Heathcock, D. Cahill, M. Gilbert, K. Aldape, I. Arrillaga-Romany, K. Ruddy, S. Greenberg, L. Nayak, N. Avgeropoulos, G. Avgeropoulos, G. Riggs, C. Reilly, N. Banerji, P. Bruns, M. Hoag, K. Gilliland, J. Trusheim, L. Bekaert, A. Borha, E. Emery, A. Busson, J.-S. Guillamo, M. Bell, C. Harrison, F. Armentano, A. Lassman, E. S. Connolly, A. Khandji, F. Iwamoto, J. Blakeley, X. Ye, A. Bergner, E. Dombi, C. Zalewski, K. Follmer, C. Halpin, L. Fayad, M. Jacobs, A. Baldwin, S. Langmead, T. Whitcomb, D. Jennings, B. Widemann, S. Plotkin, A. A. Brandes, W. Mason, J. Pichler, A. K. Nowak, M. Gil, F. Saran, C. Revil, B. Lutiger, A. F. Carpentier, B. Milojkovic-Kerklaan, P. Aftimos, S. Altintas, A. Jager, W. Gladdines, F. Lonnqvist, P. Soetekouw, M. van Linde, A. Awada, J. Schellens, D. Brandsma, A. Brenner, J. Sun, J. Floyd, C. Hart, C. Eng, L. Fichtel, A. Gruslova, A. Lodi, S. Tiziani, C. A. Bridge, A. Baldock, P. Kumthekar, P. Dilfer, S. K. Johnston, J. Jacobs, D. Corwin, L. Guyman, R. Rockne, A. Sonabend, M. Cloney, P. Canoll, K. R. Swanson, J. Bromberg, H. Schouten, R. Schaafsma, J. Baars, D. Brandsma, P. Lugtenburg, C. van Montfort, M. van den Bent, J. Doorduijn, A. Spalding, R. LaRocca, D. Haninger, T. Saaraswat, L. Coombs, S. Rai, E. Burton, G. Burzynski, S. Burzynski, T. Janicki, A. Marszalek, S. Burzynski, T. Janicki, G. Burzynski, A. Marszalek, D. Cachia, T. Smith, A. F. Cardona, L. C. Mayor, E. Jimenez, F. Hakim, C. Yepes, S. Bermudez, N. Useche, J. L. Asencio, J. A. Mejia, C. Vargas, J. M. Otero, H. Carranza, L. D. Ortiz, A. F. Cardona, L. D. Ortiz, E. Jimenez, F. Hakim, C. Yepes, N. Useche, S. Bermudez, J. L. Asencio, H. Carranza, C. Vargas, J. M. Otero, C. Bartels, A. Quintero, C. E. Restrepo, S. Gomez, L. Bernal-Vaca, M. Lema, A. F. Cardona, L. D. Ortiz, N. Useche, S. Bermudez, E. Jimenez, M. Sullivan, E. Gyan +201 moreopenaire +2 more sourcesDetecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data
Molecular Oncology, EarlyView.This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda +12 morewiley +1 more source
